Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Cancer 2018

About the conference

Conference Series Ltd  invites all the participants from all over the world to attend '2nd International Conference on Cancer Biology & Drug Delivery during October 03-04, 2018 in Los Angeles, California, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Cancer cells are the cells that divide constantly, shaping strong tumors or flooding the blood with abnormal cells. Cell division is an ordinary procedure utilized by the body for development and repair. A parent cell partitions to shape two girl cells, and these little girl cells are utilized to assemble new tissue, or to supplant cells that have kicked the bucket accordingly of maturing or harm. Healthy cells quit partitioning when there is no longer a requirement for more little daughter cells, yet growth cells keep on producing duplicates. They are likewise ready to spread starting with one a player in the body then onto the next in a procedure known as metastasis.

Why to attend???
With individuals around the globe concentrated on finding out about Cancer Biology & Drug Delivery so this is your best chance to achieve the biggest gathering of members from the Cancer BiologyDrug Delivery group. this is your single best chance to achieve the biggest collection of members from the Universities and healing centers. Lead exhibitions of new screening instruments, disseminate data about novel operators and techniques and meet with very associated speakers, appearing of Cancer and also progressions in bosom disease treatment, Current strategies and discussions in bosom tumor treatment and get name acknowledgment at this 2-day occasion. Widely acclaimed speakers, the latest systems for screening and in addition for treatment, and the most up to date overhauls in Cancer fields are signs of this meeting.


A Unique Opportunity for Advertisers and Sponsors at this International event:  cancerbiology.conferenceseries.com

Target Audience:
Cancer Biologists
Haematologist
Industrialist
Gynecologist
Oncologists
Pathologist
Cell Biologist
Nurses
Cancer Stem Cell Specialists
•Residents
Directors/Managers
Pathologists
Presidents & Vice Presidents/ Directors / Administrators
•Business Entrepreneurs
•Medical Devices Companies
Cancer Associations/ Societies

Session/Tracks

Cancer

Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. Not all tumors are cancerous; benign tumors do not spread to other parts of the body. Possible signs and symptoms include a lump, abnormal bleeding, prolonged cough, unexplained weight loss, and a change in bowel movements. While these symptoms may indicate cancer, they may have other causes. Over 100 types of cancers affect humans.

Cancer Biology

Cancer frameworks science includes the utilization of frameworks science ways to deal with tumor inquire about, keeping in mind the end goal to ponder the illness as a complex versatile framework with rising properties at different natural scales. All the more unequivocally, in light of the fact that growth traverses numerous organic, spatial and transient scales, correspondence and input instruments over the scales make a profoundly complex dynamic framework. The connections between scales are not basic or fundamentally immediate, and now and again wind up noticeably combinatorial, so frameworks approaches are basic to assess these connections quantitatively and subjectively. Malignancy frameworks science hence receives an all-encompassing perspective of growth went for incorporating its numerous organic scales, including hereditary qualities, flagging systems, epigenetics, cell conduct, histology, (pre)clinical indications and the study of disease transmission. At last, malignancy properties at one scale, e.g., histology, are clarified by properties at a scale beneath, e.g., cell conduct. In like manner, a higher scale, e.g., the study of disease transmission, can infringe on a lower scale, e.g., hereditary qualities.

  • Cancer and Cell Biology: - Malignancies are an expansive group of infections that include irregular cell development with the possibility to attack or spread to different parts of the body. They shape a subset of neoplasms. A neoplasm or tumor is a gathering of cells that have experienced unregulated development and will frequently shape a mass or irregularity however might be conveyed diffusely. All tumor cells demonstrate the six signs of malignancy. These attributes are required to deliver a harmful tumor. They incorporate.

Cell development and division truant the best possible signs.

• Continuous development and division even given opposite signs.

• Avoidance of modified cell demise

• Limitless number of cell divisions

• Promoting vein development.

• Invasion of tissue and development of metastases.

The movement from typical cells to cells that can frame a perceptible mass to through and through growth includes numerous means known as threatening movement

Organ Specific Cancer

Metastasis is a pathogenic agent's spread from an initial or primary site to a different or secondary site within the host's body, yet is typically spoken of as such spread by a cancerous tumor. The newly pathological sites, then, are metastases (mets). Cancer occurs after cells are genetically altered to proliferate rapidly and indefinitely. This uncontrolled proliferation by mitosis produces a primary heterogeneic tumour. The cells which constitute the tumor eventually undergo metaplasia, followed by dysplasia then anaplasia, resulting in a malignant phenotype. This malignancy allows for invasion into the circulation, followed by invasion to a second site for tumorigenesis.

• Breast cancer: - Breast malignancy is disease that creates from bosom tissue. Indications of bosom malignancy may incorporate a knot in the bosom, an adjustment fit as a fiddle, dimpling of the skin, liquid originating from the areola, or a red textured fix of skin. In those with far off spread of the sickness, there might be bone agony, swollen lymph hubs, shortness of breath, or yellow skin. 

• Prostate cancer: - Prostate disease is the advancement of tumor in the prostate, an organ in the male conceptive framework. Most prostate malignancies are moderate developing; be that as it may, some develop generally rapidly. The disease cells may spread from the prostate to different parts of the body, especially the bones and lymph hubs. It might at first reason no indications. In later stages it can prompt trouble urinating, blood in the pee, or agony in the pelvis, back or while urinating. An illness known as kindhearted prostatic hyperplasia may create comparative manifestations. Other late side effects may incorporate feeling tired because of low levels of red platelets

• Basal cell cancer

• Melanoma: - The essential driver of melanoma is bright light (UV) presentation in those with low levels of skin pigment. The UV light might be from either the sun or from different sources, for example, tanning devices. About 25% create from moles. Those with numerous moles, a background marked by influenced relatives, and who have poor invulnerable capacity are at more noteworthy risk. various uncommon hereditary deformities, for example, xeroderma pigmentosum additionally increment risk. Diagnosis is by biopsy of any concerning skin sore.

• Colon cancer: - A cancer of the colon or rectum, located at the lower end of the digestive tract.

Lung cancer: - A cancer that begins in the lungs and most often occurs in people who smoke.

Leukemia:- A cancer of blood-forming tissues, hindering the body's ability to fight infection.

Drug Delivery

Medication conveyance alludes to approaches, plans, advances, and frameworks for transporting a pharmaceutical compound in the body as expected to securely accomplish its coveted restorative effect. It might include logical site-focusing inside the body, or it may include encouraging fundamental pharmacokinetics; regardless, it is commonly worried about both amount and length of medication nearness. Medication conveyance is regularly drawn closer by means of a medication's synthetic definition; however it might likewise include medicinal gadgets or medication gadget mix items. Medication conveyance is an idea vigorously coordinated with measurement shape and course of organization, the last here and there being considered piece of the definition. Drug delivery technologies modify drug release profile, absorption, distribution and elimination for the benefit of improving product efficacy and safety, as well as patient convenience and compliance. Drug release is from: diffusion, degradation, swelling, and affinity-based mechanisms.

  • Thin film drug delivery
  • Magnetic drug delivery
  • Self-microemulsifying drug delivery system
  • Acoustic targeted drug delivery
  • Neural drug delivery systems
  • Drug delivery to the brain
  • Drug carrier
  • Bovine submaxillary mucin coatings
  • Retrometabolic drug design
  • Asymmetric membrane capsule

 Hematology-Oncology

Hematology, likewise spelled hematology, is the branch of pharmaceutical worried with the study, conclusion, treatment, and counteractive action of sicknesses identified with blood. Hematology incorporates the investigation of etiology. It includes treating ailments that influence the generation of blood and its segments, for example, platelets, hemoglobin, blood proteins, bone marrow, platelets, veins, spleen, and the instrument of coagulation. Such maladies may incorporate hemophilia, blood clumps, other draining issue and blood diseases, for example, leukemia, myeloma, and lymphoma. Oncology is a branch of medication that arrangements with the aversion, analysis and treatment of tumor. A therapeutic expert who hones oncology is an oncologist.

Cancer Therapy

Cancer Therapy can be dealt with by surgery, chemotherapy, radiation treatment, hormonal treatment, and focused on treatment. The decision of treatment relies on the area and grade of the tumor and the phase of the illness, and additionally the general condition of the patient. Various test tumor medicines are additionally a work in progress. Finish evacuation of the tumor without harm to whatever is left of the body (that is, accomplishing cure with almost zero unfavorable impacts) is the perfect objective of treatment and is frequently the objective by and by. Now and again this can be proficient by surgery, yet the inclination of growths to attack nearby tissue or to spread to inaccessible destinations by minute metastasis frequently restricts its viability; and chemotherapy and radiotherapy can negatively affect ordinary cells. Therefore, cure with not negligible unfavorable impacts might be acknowledged as a commonsense objective now and again; what's more healing aim, viable objectives of treatment can likewise incorporate smothering the malignancy to a subclinical state and keeping up that state for a considerable length of time of good personal satisfaction, and palliative care without therapeutic expectation (for cutting edge arrange metastatic diseases).

Oncogenomics

Oncogenomics is a sub-field of genomics that characterizes cancer-associated genes. It focuses on genomic, epigenomic and transcript alterations in Cancer. Cancer is a genetic disease caused by accumulation of DNA mutations and epigenetic alterations leading to unrestrained cell proliferation and neoplasm formation. The goal of Oncogenomics is to identify new oncogenes or tumor suppressor genes that may provide new insights into cancer diagnosis, predicting clinical outcome of cancers and new targets for cancer therapies. The success of targeted cancer therapies such as Gleevec, Herceptin and Avastin raised the hope for oncogenomics to elucidate new targets for cancer treatment.

Cancer Imaging

Cancer imaging is the procedure and procedure of making visual representations of the inside of a body for clinical investigation and medicinal mediation, and additionally visual representation of the capacity of a few organs or tissues (physiology). Therapeutic imaging tries to uncover inward structures covered up by the skin and bones, and to analyze and treat malady. Restorative imaging likewise builds up a database of typical life structures and physiology to make it conceivable to distinguish variations from the norm. In spite of the fact that imaging of expelled organs and tissues can be performed for medicinal reasons, such strategies are generally considered a portion of pathology rather than therapeutic imaging.

Cancer Biomarkers

A Cancer marker or tumor marker is a biomarker found in blood, urine, or body tissues that can be hoisted by the nearness of one or more sorts of growth. There are various tumor markers, every demonstrative of a specific illness process, and they are utilized as a part of oncology to distinguish the nearness of malignancy. A hoisted level of a tumor marker can show growth; notwithstanding, there can likewise be different reasons for the height. Tumor markers can be delivered straightforwardly by the tumor or by non-tumor cells as a reaction to the nearness of a tumor.

Cancer Pharmacology

Disease Chemotherapy and Pharmacology is an associate explored restorative diary covering oncological pharmacotherapy. It was built up in 1978 and is distributed by Springer Science and Business Media. The editors-in-boss are H. Newell (Newcastle University) and E.A. Sausville (University of Maryland). It has been MEDLINE and Pubmed filed since its first issue.

Gynecologic Oncology         

Gynecologic oncology is a specific field of drug that spotlights on malignancies of the female conceptive framework, including ovarian disease, uterine growth, vaginal tumor, cervical disease, and vulvar malignancy. As pros, they have broad preparing in the analysis and treatment of these growths. In the United States, 82,000 ladies are determined to have gynecologic disease annually. In 2013, an expected 91,730 were diagnosed. The Society of Gynecologic Oncology and the European Society of Gynecological Oncology are proficient associations for gynecologic oncologists, and the Gynecologic Oncology Group is an expert association for gynecological oncologists and in addition other restorative experts who manage gynecologic growths. The Foundation for Women's Cancer is the major U.S. association that brings issues to light and research financing and gives instructive projects and materials about gynecologic growths.

Cancer Stem Cells

Malignancy undifferentiated organisms are disease cells that have attributes connected with ordinary immature microorganisms, particularly the capacity to offer ascent to all cell sorts found in a specific growth test. Cancer Stem Cells are in this way tumorigenic, maybe rather than other non-tumorigenic growth cells. Cancer Stem Cells may create tumors through the undifferentiated organism procedures of self-recharging and separation into numerous cell sorts. Such cells are guessed to hold on in tumors as a particular populace and cause backslide and metastasis by offering ascend to new tumors. Thus, advancement of particular treatments focused at CSCs holds seek after change of survival and personal satisfaction of growth patients, particularly for patients with metastatic illness.

Molecular Cancer

Molecular Cancer is an open get to, companion looked into diary intrigued by pulling in excellent unique research and audits that present or highlight huge advances in every aspect of disease and related biomedical science. Sub-atomic Cancer gives a vital discussion to energizing discoveries in disease related research, exhibiting an unparalleled chance to impart data to masters and general society. Atomic Cancer is occupied with articles from essential, translational and clinical research. Subjects of intrigue incorporate, however are not constrained to: tumor science, angiogenesis, creature models, metastasis, malignancy antigens and the invulnerable reaction to them, cell flagging and sub-atomic science, the study of disease transmission, hereditary and sub-atomic profiling of growth targets, growth undifferentiated organisms, DNA harm and repair, cell cycle, apoptosis, virology and immunization and neutralizer based disease treatments.

DNA Repair and Cancer

In view of inborn confinements in the DNA repair instruments, if people lived sufficiently long, they would all in the long run create cancer. There are no less than 34 Inherited human DNA repair quality changes that expansion malignancy chance. A hefty portion of these changes cause DNA repair to be less compelling than typical. Specifically, Hereditary nonpolyposis colorectal disease (HNPCC) is unequivocally connected with particular transformations in the DNA befuddle repair pathway. BRCA1 and BRCA2, two well known qualities whose changes give a colossally expanded danger of bosom disease on bearers, are both connected with countless repair pathways, particularly NHEJ and homologous recombination.

Renal Cell Cancers: - Renal cell carcinoma is likewise called hypernephroma, renal adenocarcinoma, or renal or kidney growth. It's the most widely recognized sort of kidney tumor found in grown-ups. The kidneys are organs in your body that dispose of waste, while likewise managing liquid adjust. There are small tubes in the kidneys called tubules. It can be defined as a kidney disease that starts in the coating of the proximal convoluted tubule, a part of the little tubes in the kidney that vehicle squander atoms from the blood to the pee. RCC is the most well-known kind of kidney disease in grown-ups, in charge of around 90–95% of cases.

Immunotherapy

Immunotherapy is the "treatment of sickness by instigating, improving, or smothering a safe response". Immunotherapies intended to evoke or increase an insusceptible reaction are named actuation immunotherapies, while immunotherapies that decrease or stifle are delegated concealment immunotherapies. Immunomodulatory regimens frequently have less symptoms than existing medications, including less potential for making resistance in microbial disease. Cell-based immunotherapies are compelling for a few diseases. Invulnerable effector cells, for example, lymphocytes, macrophages, dendritic cells, characteristic executioner cells, cytotoxic T lymphocytes, cooperate to shield the body against malignancy by focusing on strange antigens communicated on the surface of tumor cells.

Cancer Treatments and Vaccines

There are numerous sorts of tumor treatment. The sorts of treatment that one needs to rely on upon the kind of disease one have and how best in class it is. A few people with tumor will have one and only treatment. Be that as it may, the vast majority have a blend of medicines, for example, surgery with chemotherapy and/or radiation treatment. One may likewise have immunotherapy, focused on treatment, or hormone treatment. Clinical trials may likewise be a possibility for every one of us. Clinical trials are research considers that include individuals. Understanding what they are and how they function can help you choose if partaking in a trial is a decent alternative for every one of us.

  • Cancer Screening: - Disease screening plans to distinguish malignancy before manifestations show up. This may include blood tests, pee tests, different tests, or restorative imaging. The advantages of screening regarding disease counteractive action, early location and ensuing treatment must be weighed against any harms. Screening can prompt false positive results and consequent intrusive procedures. Screening can likewise prompt false negative results, where a current malignancy is missed. Contention emerges when it is not clear if the advantages of screening exceed the dangers of the screening system itself, and any subsequent indicative tests and medications. Screening tests must be viable, protected, all around endured with acceptably low rates of false positive and false negative results. On the off chance that indications of growth are recognized, more conclusive and obtrusive follow-up tests are performed to achieve a determination. Screening for growth can prompt malignancy aversion and prior determination. Early determination may prompt higher rates of fruitful treatment and developed life. Be that as it may, it might likewise dishonestly seem to build the opportunity to death through lead time inclination or length time predisposition.

Chemotherapy

Chemotherapy is a class of tumor treatment that utilizations one or more hostile to growth drugs (chemotherapeutic operators) as a major aspect of an institutionalized chemotherapy regimen. Chemotherapy might be given with a therapeutic expectation (which quite often includes blends of medications), or it might plan to drag out life or to lessen side effects (palliative chemotherapy). Chemotherapy is one of the real classifications of therapeutic oncology (the medicinal teach particularly gave to pharmacotherapy for malignancy).

Cancer Epidemiology

The study of disease transmission is the study and investigation of the examples, causes, and impacts of wellbeing and illness conditions in characterized populaces. It is the foundation of general wellbeing, and shapes arrangement choices and proof based practice by distinguishing hazard components for ailment and focuses for preventive human services. Disease transmission experts help with study outline, accumulation, and measurable investigation of information, change translation and spread of results (counting peer survey and intermittent precise audit). The study of disease transmission has created system utilized as a part of clinical research, general wellbeing thinks about, and, to a lesser degree, fundamental research in the natural sciences.

Global Market for Cancer Treatments

More than 20 tumor sorts are being treated with one or a greater amount of the 70 new disease medicines that have been propelled in the previous five years, with the supported surge in imaginative treatments driving the worldwide oncology market to $107 billion in 2015. In any case, a large portion of these medications are not yet accessible to patients in many nations, and notwithstanding when enrolled they may not be repaid under open protection programs, as indicated by another study discharged today by the IMS Institute for Healthcare Informatics.

Cancer Treatments and Market Dynamics

The pace of progress in growth care is quickening. A bunch of inventive medications, regularly consolidated with other new or existing pharmaceuticals, and every now and again connected with biomarkers, are rising up out of the innovative work pipeline. Numerous are for tumor sorts connected with low survival rates and where patients have constrained choices. The scene is moving quickly, conveying new intricacy to oncologists, payers and governments who all hope to give proper care to patients while guaranteeing the supportability of medicinal services frameworks. Prior conclusion, longer treatment term and expanded adequacy of medication treatments are adding to rising levels of spending on prescriptions for malignancy mind.

 

Market Analysis

Cancer Biology & Drug Delivery Market Overview:

Global Oncology/Cancer Biology Market is relied upon to collect $111.9 billion by 2020, enlisting a CAGR of 7.1% amid the conjecture time frame 2014 to 2020. Late advance in organic treatments has enlarged the size of restorative focuses for treatment of malignancy with the distinguishing proof of tumor cell particular qualities. Immunotherapies/biologics are developing as potential treatments to locate the changeless cure for different growth sorts. Among different biologics, drugs in view of monoclonal antibodies (mAbs) have increased critical consideration as of late because of their high adequacy.

Worldwide tumor drugs showcase represented $78,238.9 million of every 2015. The growth drugs advertise is driven by the developing predominance of different sorts of tumor, expanding interest of organic and focused on sedate treatments, persistent patent expiry of key disease drugs and the rising effect of biosimilars. In any case, the high cost of medication improvement, the danger of disappointment and the antagonistic impacts of disease tranquilize treatment, especially chemotherapy, blocks the market development. Created countries have executed strict directions for the outline and advancement of growth drugs. USFDA and European Union have embraced noteworthy activities to fuel the development of the growth drugs showcase by giving pre-advertise endorsement to potential medications under clinical advancement. Asia-Pacific and LAMEA are promising districts for leading clinical trials due a vast populace base and the minimal effort of clinical trials when contrasted with North America and Europe. In any case, headway of growth medicate look into inferable from natural/directed treatments and customized meds hold promising open doors for pharmaceutical, bio-pharmaceutical and biotechnology organizations occupied with creating disease drugs.

Key Findings of Oncology Drugs Market:

Immunotherapy/natural medications portion anticipated that would develop at a twofold digit CAGR amid the figure time frame and would develop at the quickest rate. Blood malignancy is the real income producing fragment in the worldwide oncology tranquilize application showcase be that as it may, lung tumor section is relied upon to become quickest among all. At present, North America gathers a noteworthy offer in the oncology drugs advertise, as far as market measure. Asia Pacific oncology medicate showcase is overwhelmed by China and Japan, together adding to ~60% of the provincial market income in 2014. A lion's share of the oncology medicate makers have received joint effort and securing as key formative methodologies to accomplish a focused edge. In addition, organizations are likewise shaping vital partnerships to quicken the procedure of clinical trials. These procedures have turned out to be successful in helping key market players hold their driving positions in the worldwide oncology drugs advertise. Enter organizations profiled in the report are Roche diagnostics, Novartis AG, Celgene Corporation, AstraZeneca, Johnson and Johnson, Merck and Co., Eli Lilly and Co., Amgen Inc., Pfizer and GlaxoSmithKline.

Market Segment Review:

The focused structure of the worldwide malignancy drugs advertise is broke down utilizing Porter's Five Forces Model. As indicated by Porter's investigation, the haggling energy of purchasers is low due high cost of medications, lesser information about the items/drugs. Nonetheless, the dealing energy of providers tends to direct inferable from their lower fixation and prerequisite of higher capital venture. Growth drugs are for the most part secured with IPR rights in this manner, prompts increment in the boundaries for new participants.

Worldwide tumor drugs showcase by helpful modalities is portioned into chemotherapy, Targeted treatment, Immunotherapy, Hormonal treatment and others. Immunotherapy overwhelms the worldwide market for tumor medicates because of its high adequacy and less reactions. Monoclonal antibodies, for example, trastuzumab, bevacizumab and rituximab are potential immunotherapeutic specialists that have accomplished generous deals. The growth immunotherapy showcase is essentially determined by tremendous research speculations from multinational organizations alongside inquire about coordinated efforts for the improvement of malignancy immunotherapeutics. In the course of recent years, directed malignancy treatments have increased noteworthy consideration because of their tumor cell particular activity in shielding solid cells from the lethal impacts of growth drugs.

Worldwide growth drugs showcase by malignancy sort is portioned into Blood tumor, Breast disease, gastrointestinal tract growth, Prostate tumor, Lung Cancer, Skin Cancer and other malignancy. Among these distinctive growth sorts, blood disease was the biggest income creating section in 2015. The development of blood disease fragment is significantly because of the high cost of the medications used to treat blood growth. The pervasiveness of blood growth is less in created countries, be that as it may, the determination rate is over 90% and practically every individual determined to have blood malignancy looks for finish treatment for the cure of blood tumor. Because of the high expendable wages of purchasers in created countries, costly medication treatment of blood malignancy is reasonable in these districts. Lion's share of the as of late advanced biologics (drugs in view of monoclonal antibodies) demonstrated a noteworthy cure for blood tumor; consequently, use rate of these medication is high, in spite of their high cost.

Geographic Review:

Geologically, the Global disease drugs advertise fragments into North America, Europe, Asia-Pacific and LAMEA. North America commands the market for disease sedates as the district houses organizations occupied with the advancement of tumor drugs. Moreover, the dispensable livelihoods of customers and medical coverage cover forever undermining sicknesses in North America are high which expands the reasonableness of disease treatment. As of late, US Food and Drug Administration (USFDA) has taken activities to help the development of tumor drugs advertise by giving pre-showcase endorsement to the medications, which are in the clinical stage; in this way, quickening the clinical advancement.

Countless in North America demonstrate generous interest in R&D from multinational organizations and also investigate associations. Europe is the second biggest market for malignancy sedates and is relied upon to develop at a CAGR of 6.8% amid the investigation time frame. In North America and Europe, a dominant part of the multinational players have concentrated on the improvement of biologics or immunotherapeutic attributable to its high viability and target particular activity. The exploration for tumor medicates in Asia-Pacific and LAMEA is rising with the concentration towards the advancement of biosimilars. The commonness of different growth sorts is high in creating nations which render these areas as promising areas to lead clinical trials. In addition, the cost of clinical research is low in these districts because of the accessibility of an enormous populace base and ideal government approaches.

Japan Oncology/Cancer Drugs Market Review:

Japan has largest share to the total Asia Pacific cancer drug market due to the high prevalence of cancer in Japanese population. Lung cancer is the major cause of death in Japanese population. The total healthcare expenditure of japan was $495 billion in 2013. 

Several new drugs are now approved in Japan, including Afinitor, Avastin, Jevtana, Sutent and Zytiga, which could trigger a growth of cancer drug market and a shift in the treatment paradigm in the foreseen future.

Access to new drugs might be delayed in Japan due to strict regulatory processes in Japan. Pharmaceutical and Medical Devices Agency (PMDA) and Ministry of Health, Labor and Welfare (MHLW), are the regulatory agencies in Japan. Jevtana (Cabazitaxel acetonate) and MabCampath (Alemtuzumab), by Sanofi, are recently approved cancer drugs in Japan.

Japanese government health insurance is the most generous in Asia and offers the highest rates of reimbursement. The government offers coverage for approved treatments, including treatments for cancer, to all citizens. The treatments are eligible for coverage as long as they are approved by Japan’s MHLW.

          Japan oncology/cancer drugs market by therapeutic modalities, 2020

Competitive Review:

The key players profiled in this report include Amgen Inc., Johnson & Johnson, GlaxoSmithKline, Eli lilly & Co., Roche diagnostics, Novartis AG, Pfizer, Merck & Co., Sanofi, and Celgene Corporation. Roche, Novartis and Celgene are the top three players in Global cancer drugs market with a wide of cancer product portfolio. The three companies contribute to ~60% of the total market share. The immunotherapeutics developed by Roche namely Rituxan, Avastin and Herceptin achieved blockbuster sales in 2013. A majority of the cancer drug manufacturers have adopted collaboration, approval and acquisition as their key developmental strategies to achieve a competitive edge. Moreover, companies are forming strategic alliances to accelerate their clinical developments. These strategies have proved to be effective in helping key players retain their leading positions in the global market.

ONCOLOGY DRUGS MARKET KEY BENEFITS

  • The report provides the quantitative analysis of the current trends, size and estimations for the forecast period 2013-2020 that assists in identifying the prevailing opportunities to capitalize on

  • The report helps in understanding the strategies adopted by various companies for consolidating their positions in the industry.

  • The report provides comprehensive analysis of factors that drive and restrict the growth of the cancer drugs market

  • Demand and supply conditions of cancer drugs across all geographic regions are comprehensively analyzed

  • Competitive intelligence (of leading manufacturers) helps in understanding the competitive market scenario and opportunities across the geographies

  • SWOT analysis of the key market players is provided to illustrate the business strategies adopted by the companies

ONCOLOGY/CANCER DRUGS MARKET SEGMENTATION

The Oncology drugs market is segmented by the therapeutic modalities, cancer types and geography.

BY THERAPEUTIC MODALITIES

  • Chemotherapy

  • Targeted Therapy

  • Immunotherapy (Biologic Therapy)

  • Hormonal Therapy

  • Others

BY CANCER TYPES

  • Blood Cancer

  • Breast Cancer

  • Gastrointestinal Cancer

  • Prostate Cancer

  • Respiratory/Lung Cancer

  • Skin Cancer

  • Other Cancers

 

 

BY GEOGRAPHY

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
    • Germany
    • France
    • United Kingdom
    • Others
  • Asia-Pacific
    • India
    • China
    • Japan
    • Australia
    • Others
  • LAMEA
    • GCC (Gulf Corporation Council)
    • Others

Importance and Scope:

The Importance of Cancer 2018 is to redesign, clinically critical gathering of people concerning the confirmation supporting ebb and flow Advances in finding and treatment in the field of Cancer Research. Specialists and researchers over the globe will trade perspectives and ideas. Understudies/Scholars from various colleges assemble and improve their insight. Demonstrative and Pharmaceutical firms will show their novel items and administrations, which permit them to build up their business universally. Cancer 2018 is a universal stage for showing research, exchanging ideas concerning it and along these lines, contributes towards spreading data in research strategies, in analysis and counteractive action of Caner and Related sickness and so forth for the upside of every youthful specialist, Pharmaceutical firms, researchers and the scholarly world. Cancer 2018 is wherever the more drawn out term of show new diagnostics strategies and Instruments utilized for treatment and finding and novel medication. This occasion brings along senior brand advertisers and office administrators to investigate advancing and publicizing openings on Pharmaceutical partnerships.

Why Los Angeles, USA?

Los Angeles officially the City of Los Angeles and often known by its initials L.A., is the cultural, financial, and commercial center of Southern California. With a U.S. Census-estimated 2016 population of 3,976,322 it is the second most populous city in the United States (after New York City) and the most populous city in the state of California. There are three public universities located within the city limits: California State University, Los Angeles (CSULA), California State University, Northridge (CSUN) and University of California, Los Angeles (UCLA). There are 841 museums and art galleries in Los Angeles County. In fact, Los Angeles has more museums per capita than any other city in the world. Some of the notable museums are the Los Angeles County Museum of Art (the largest art museum in the Western United States.

Conference Highlights:

Tracks 1: Cancer

Track 2: Cancer Biology

Track 3: Organ Specific Cancer

Track 4: Drug Delivery

Track 5: Hematology-Oncology

Track 6: Cancer Therapy

Track 7: Oncogenomics

Track 8: Cancer Imaging

Track 9: Cancer Biomarkers

Track 10: Cancer Pharmacology

Track 11: Gynecologic Oncology

Track 12: Cancer Stem Cells

Track 13: Molecular Cancer

Track 14: DNA Repair and Cancer

Track 15: Immunotherapy

Track 16: Cancer Treatments and Vaccines

Track 17: Chemotherapy

Track 18: Cancer Epidemiology

Track 19: Global Market for Cancer Treatments

Track 20: Cancer Treatments and Market Dynamics

Why to attend Cancer Biology & Drug Delivery?

Team Cancer Biology & Drug Delivery aims to deliver a perfect platform to the scientific and industry personnel to share their knowledge and expertise. It gives opportunity to conduct demonstrations, distribute information, meet with current and potential speakers/Delegates all around the world which are working on the very emerging field of Cancer Biology & Drug Delivery, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in Cancer Biology & Drug Delivery fields are hallmarks of this conference.

A Unique Opportunity for Advertisers and Sponsors at this International event:

https://cancerbiology.conferenceseries.com/

Target Audience:

For Cancer Biology & Drug Delivery mainly the target audiences are Cancer Biology & Drug Delivery Scientists, Students, Researchers, Faculty, Cancer Biology & Drug Delivery Associations and Societies, Medical Colleges, Oncologist, Pathologist, Haematologist and Neurologist.

Hospitals related to Cancer in California:

  • California Northstate University College of Medicine
  • Charles R. Drew University of Medicine and Science
  • Keck School of Medicine of University of Southern California
  • Loma Linda University School of Medicine
  • Stanford University School of Medicine
  • University of California, Davis School of Medicine
  • University of California, Irvine School of Medicine
  • David Geffen School of Medicine at UCLA
  • University of California, Riverside School of Medicine
  • University of California, San Diego School of Medicine
  • Hospitals related to Cancer in USA:

There are 902 Hospitals working on Cancer in USA few of them are listed below:

  • Memorial Sloan Kettering (MSK) Cancer Center, New York City

  • University of Texas M.D. Anderson Cancer Center, Houston

  • Mayo Clinic, Rochester, Minnesota

  • Dana-Farber/Brigham and Women's Cancer Center, Boston

  • Johns Hopkins Hospital, Baltimore, Maryland

  • University of Washington Medical Center, Seattle

  • Massachusetts General Hospital, Boston

  • UCSF Medical Center, San Francisco

  • Stanford Hospital and Clinics, Stanford, California

  • Hospitals of the University of Pennsylvania–Penn Presbyterian, Philadelphia

  • City of Hope, Los Angeles

  • Cleveland Clinic

  • New York–Presbyterian University Hospital of Columbia and Cornell, New York City

  • University of Colorado Hospital, Denver

  • Moffitt Cancer Center, Tampa, Florida

  • Northwestern Memorial Hospital, Chicago

  • Seidman Cancer Center at UH Case Medical, Cleveland

  • Fox Chase Cancer Center, Philadelphia

There are 9368 Hospitals working on Cancer Worldwide few of them are listed below:

  • University of Texas MD Anderson Cancer Center (Houston)

  • University of Texas MD Anderson Cancer Center (Houston)

  • Memorial Sloan-Kettering Cancer Center (New York) 

  • Memorial Sloan-Kettering Cancer Center (New York)

  • Johns Hopkins Hospital (Baltimore) 

  • Mayo Clinic (Rochester, Minn.)

  • Dana-Farber/Brigham and Women's Cancer Center (Boston)

  • Duke University Medical Center (Durham, N.C.) 

  • Seattle Cancer Care Alliance/University of Washington Medical Center (Seattle)

  • University of Chicago Hospitals

  • Johns Hopkins Hospital (Baltimore) and UCLA Medical Center (Los Angeles)

  • Massachusetts General Hospital (Boston)

  • UCLA Medical Center (Los Angeles)

  • Massachusetts General Hospital (Boston)

  • Roswell Park Cancer Institute (Buffalo, N.Y.) 

  • UCSF Medical Center (San Francisco)

  • Top universities/ College related to Cancer in Philadelphia:

  • Abramson Family Cancer Research Institute

  • Wistar Institute: Conejo-Garcia Jose R MD

  • Fox Chase Cancer Center

  • Cancer Treatment Centers of America at Eastern Regional Medical Center

  • Thomas Jefferson University

  • Abramson Cancer Center Hospital University of Pennsylvania (HUP)

  • Kimmel Cancer Center

  • University of Pennsylvania Hematology/Oncology Fellowship

  • Fels Institute

  • Abramson Cancer Center: Feldman Arthur M MD

  • Top universities/ College related to Cancer in USA:

There are about 60 universities/ Colleges working on Cancer in USA few of them are listed below:

  • Massachusetts Institute of Technology

  • University of California at Los Angeles

  • Johns Hopkins University

  • Texas A & M University

  • Princeton University

  • California Institute of Technology – Caltech

  • Yale University

  • Cornell University

  • Georgia University of Technology

  • Emory University

  • Stanford University

  • Northwestern University

  • University of Miami

  • Top universities/ College related to Cancer in Worldwide:

There are 2443 universities/ Colleges working on Cancer Worldwide few of them are listed below:

  • Harvard University

  • University of Cambridge

  • University of Oxford

  • Massachusetts Institute of Technology

  • Johns Hopkins University

  • Stanford University

  • University of California, San Francisco (UCSF)

  • Yale University

  • Karolinska Instituet

  • University of California, Los Angeles (UCLA)

  • The University of Sydney

  • The University of Melbourne

  • King’s College London

  • University of Michigan

  • McGill University

  • The University of Edinburgh

  • Kyoto University

  • Hong Kong University of Science and Technology

  • University of Tsukuba

  • Major Associations/ Societies related to Cancer

  • American Cancer Society

  • Cancer Research Institute

  • Children’s Cancer research Fund

  • The Lance Armstrong Foundation

  • Vietnam Cancer Charities Fund

  • Cancer Survivor’s Fund

  • Acoustic Neuroma Association

  • Acoustic Neuroma Association of Australia

  • Acoustic Neuroma Association of Canada

  • American Association for Cancer Research

  • American Bone Marrow Donor Registry

  • American Brain Tumor Association

  • Companies related to Cancer Worldwide:

  • Abbott Laboratories

  • Abbott Nutrition

  • Abbvie And Biogen

  • Acadia Pharmaceuticals

  • Acorda Therapeutics

  • Actelion Pharmaceuticals

  • Acura Pharmaceuticals

  • Aegerion Pharmaceuticals

  • Akrimax Pharmaceuticals

  • Alcon Laboratories

  • Alexion Pharmaceuticals

  • Amneal Pharmaceuticals

  • Amphastar Pharmaceuticals

  • Ani Pharmaceuticals

  • Aptalis Pharmaceutical Technologies

  • Aqua Pharmaceuticals

  • Atnahs Pharma

  • Aytu Bioscience

Past Report

The success of the International Conference on Cancer Biology & Drug Delivery has given us the prospect to bring the gathering one more time. Conference series LLC hosted the “2nd International Conference on Cancer Biology & Drug Delivery” during October 03-04, 2018 in Los Angeles, USA

The conference was focused on Cancer Biology & Drug Delivery studies with the theme ‘’Novel Techniques and Emerging Research in Cancer. The meeting engrossed a vicinity of comprehensive discussions on novel subjects like Cancer and Cell Biology, Organ Specific Cancer, Oncogenomics, Cancer Imaging, Cancer Biomarkers, Cancer Pharmacology, Hematology-Oncology, Epithelial Cancers, Renal Cell Cancers, Gynecologic Oncology, Cancer Stem Cells, Molecular Cancer, DNA Repair and Cancer, Immunotherapy, Cancer Therapy, Drug Delivery, Targeted Drug Delivery, Drug Transplantation Techniques, Cancer Treatments and Vaccines, Cancer Screening, Chemotherapy, Cancer Epidemiology, Global Market for Cancer Treatments.

The conference was embarked with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

  • Diana Anderson, University of Bradford, UK

  • Michael Retsky, Harvard TH Chan School of Public Health, USA

  • Jianhua Luo, University of Pittsburgh School of Medicine, USA

  • Andrei L Gartel, University of Illinois, USA

  • Myron Arlen, Hofstra University, USA

Best Poster Awardees:

Tittle: -  A DM1 gold nanoparticle (MTC-100038) is more effective than sorafenib in multiple murine models of hepatocellular carcinoma

Kelly Conlon, Midatech Pharma, UK

Conference Series Ltd offers its heartfelt appreciation to Organizing Committee Members, dexterous of field, various outside experts, company representatives and is obliged to other eminent personalities who interlaced with Conference Series Ltd and supported the conference in every aspect, without which the conference would not have been possible.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Cancer 2017, Conference Series Ltd would like to announce the commencement of the “2nd International Conference on Cancer Biology & Drug Delivery” to be held during October 03-04, 2018,  Los Angeles, USA. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Cancer Biology & Drug Delivery.

For More details: https://cancerbiology.conferenceseries.com/

 Let us meet again @ Cancer 2018

To Collaborate Scientific Professionals around the World

Conference Date October 03-04, 2018

For Sponsors & Exhibitors

sponsors@conferenceseries.com

Speaker Opportunity

Day 1 Day 2

Supported By

Journal of Cancer Science and Therapy Journal of Carcinogenesis and Mutagenesis Advances in Oncology Research and Treatments

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Keytopics

  • Approaches In Cancer Therapy
  • Basal Cell Cancer
  • Breast Cancer
  • Cancer
  • Cancer Biology
  • Cancer Biomarkers
  • Cancer Biomarkers
  • Cancer Biopsy
  • Cancer Cell Biology
  • Cancer Diagnostics
  • Cancer Diagnostics Market
  • Cancer Diagnostics Types
  • Cancer Epidemiology
  • Cancer Imaging
  • Cancer Innovations
  • Cancer Pharmacology
  • Cancer Stem Cells
  • Cancer Therapy
  • Cancer Treatments And Vaccines
  • Carcinoma
  • Chemotherapy
  • Colon Cancer
  • DNA Repair And Cancer
  • Drug Delivery
  • Genomic Biomarkers In Cancer
  • Gynecologic Oncology
  • Hematology
  • Immunotherapy
  • Leukemia
  • Lung Cancer
  • Lymphoma
  • Melanoma
  • Molecular Cancer
  • Nanotechnology In Cancer
  • Oncogenomics
  • Oncology
  • Oncology Nursing
  • Organ Specific Cancer
  • Pancreatic And Colorectal Cancer
  • Prostate Cancer
  • Radiology And Imaging In Cancer
  • Recent Diagnostics Technologies